The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. DiaMedica Therapeutics, Inc. (DMAC) is a stock that can certainly ...

View DiaMedica Therapeutics Inc. DMAC stock quote prices, financial information, real-time forecasts, and company news from CNN.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The average one-year price target for DiaMedica Therapeutics (NasdaqCM:DMAC) has been revised to $15.81 / share. This is an increase of 25.68% from the prior estimate of $12.58 dated November 14, 2025 ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

The latest price target for DiaMedica Therapeutics (NASDAQ:DMAC) was reported by Cantor Fitzgerald on November 14, 2025. The analyst firm set a price target for $25.00 expecting DMAC to rise to within ...